MCI MCI
Company Profile ↓Company Overview
MCI (MCI) is a publicly traded company listed on with a market capitalization of $336.83M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 25.3% per year over the last five years.
Revenue has grown at a 23.0% CAGR over the past five years.
Trades at an undemanding P/E of 9.4.
Maintains a net profit margin of 93.0%.
Carries low leverage with a debt-to-equity ratio of 0.22.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $30.18M (-20.4% YoY); net profit $28.06M.
- Trailing 12 Months Year-on-year growth — revenue -20.4%, earnings -21.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 23.0%, profit CAGR 25.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 23.01% |
| 1 Year: | -20.42% |
Compounded Profit Growth
| 5 Years: | 25.30% |
| 1 Year: | -21.14% |
Stock Price Performance
| 1 Year: | -13.40% |
| 6 Months: | -18.81% |
| 3 Months: | -3.77% |
| 1 Month: | -5.36% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)35.74 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 93.0%.
- Compounding revenue at 23.0% over 5 years.
- Profit CAGR of 25.3% over 5 years.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 16.21M | 39.15M | 37.92M | 30.18M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 1.18M | 1.34M | 1.39M | 1.41M |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 1.71M | 2.08M | 1.78M | 2.57M |
| Pretax Income | - | 15.03M | 37.82M | 36.53M | 28.77M |
| Tax Provision | - | 766.22K | 857.36K | 950.20K | 710.20K |
| Net Income | - | 14.26M | 36.96M | 35.58M | 28.06M |
| Diluted EPS | 2.60 | 0.71 | 1.82 | 1.75 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 386.05M | 393.93M | 406.24M | 431.22M |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 13.23M | 14.87M | 17.20M | 32.12M |
| Inventory | - | - | - | - | - |
| Receivables | - | 5.46M | 6.51M | 10.09M | 5.83M |
| Total Liabilities | - | 54.41M | 54.11M | 62.68M | 89.92M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 46.00M | 42.31M | 45.85M | 74.72M |
| Total Equity | - | 331.64M | 339.83M | 343.56M | 341.30M |
| Shares Outstanding | - | 20.26M | 20.26M | 20.40M | 20.53M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 3.92M | 32.02M | 28.14M | 18.57M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | -11.84M | -30.38M | -25.80M | -3.64M |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | 3.92M | 32.02M | 28.14M | 18.57M |
| Net Change in Cash | - | -7.92M | 1.64M | 2.33M | 14.92M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 88.0% | 94.4% | 93.8% | 93.0% |
| ROE % | - | 4.3% | 10.9% | 10.4% | 8.2% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MCI
(MCI) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPT2xFWmExR1lUelhrUlNiVUNpLTh4NzBhLUszWm1iWXR3V2xhQnJzdi1XWktPb09lczJTMTE3MXRvMUZ0amFpWUUzc1BQRUdCQkpKTDIxNDRVdUNiYVlKV2FOMzF6UmhNTmMwTnR1UjkzRU54UjlsOVA4TlZKRFVJdzhmVFdIVENpaFZ4RW…
MCI Capital Alternatywna Spolka Inwestycyjna S.A. Revenue Breakdown – GPW:MCI - TradingView
<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE1OcUF1eEo3N2llc2xXR1U2MzE2WHg5bWpiYUZ5a0M3S2oyQnhqcENzbWU0S0xHRW1qTVlFclROT1VWN041ODk0Q2FBbmdETFNiY1ltNFIyYVdjWjJ0N1VhbDZ1RjdUQTRKMmZyZkNhOU9TZw?oc=5" target="_blank">MCI Capital A…
Barings Corporate Investors (MCI) Modestly Lower, Testing Support Levels Within a Tight Range - Merger Arbitrage - po-news-eg.net
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxPLXRJTE5iaXRaZVBjLTV2alJUV05qczhIMTBvblR2Qm1qb3BsVjZXYXlUSUYydVptUWxxM0RqNkVISG1udUl2UzV0WWFJcDFoM2xVMEN6TUhyTlFUQVVaVmp5ZnoxNXNhSEg4THpTZU1VMkRhT1R1Z2VUeVkxaWhldlk1OTVOeEhQaVZicn…
National Rice Stocks Stable, Sufficient For Six Months’ Supply – Deputy Minister - Malaysia-China Insight
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNb2tFVWhtaGViekRUZkIyXzNROVA2V2VkRDdGQTdENW9penR6RGo3ZFgyY1RwcUdGT2hCOHV6LTRSUDBad0w1LUVrX05qWXFoSHRqdmxiZ2VuNmlqYnFPMG05UnNHcXVTd1ZWLVMyRnNUT0Q1azZSR2RMTTBQcEdTbHQ2c2twLU5pVmc3aV…
MCI: Easing Share Price Leads To Premium Decline; This Could Be The Reason (NYSE:MCI) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOT1pvRVVSUVhuclR4MXhHNGFJcmdTSkdaeVFxTnM4Mm9YcmdOX3lMZFFCTzZjamhKQ0FuMUVrSDM0aEM4U1BMMUhBa1A4OS0wOEo1Q1ZlOTNZaVl3Z2tlTzNxMTU0YWNRTkZrUGY0ZmpSZkNsS1R5QXRmTmZ4RlVBd3dfQjhodUJrMm1TZE…
Barings Corporate Investors (MCI) Holds Steady Near Key Support as Range-Bound Trading Continues - ETF NAV Deviation - Bölüm Sonu Canavarı
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxNZ0poNUNGYVczNUhwUDV4T0s0S1RoZHpSbDFvVjk3UV8yR2dmVTlsWUNrMGhYMEk4cThmX005aGJ4cklPc0lWeGcySG1EM3Bxb0FaUE1HX01rdFpzcXJjZ3k1WmppdTkzUHp6VHRkMERaUTlQck5ya1JBVkRKa0xLYkpDZlNFZ0x0cy1xY0…
MCI — Frequently Asked Questions
What is the current share price of MCI?
As of 2026-08-05 17:25 PDT, MCI trades at $16.41 on NASDAQ/NYSE. Its 52-week range is $16.30 to $21.48.
What is the market capitalisation of MCI?
MCI has a market capitalisation of $336.83M on NASDAQ/NYSE.
What is the P/E ratio of MCI?
MCI trades at a trailing price-to-earnings (P/E) ratio of 9.38. Its price-to-book (P/B) ratio is 0.99.
What is the return on equity (ROE) of MCI?
MCI has a return on equity (ROE) of 8.22%.
Is MCI a good stock to buy?
This page provides a data-driven analysis of MCI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.